Physician profile
Douglas P Prevost
NPI 1952376022
$4,880.15
in general payments reported to CMS, 2019-2025
14 companies · $1,808 in 2025
The $1,808 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.92 · 2020: $101 · 2021: $680 · 2022: $1,718 · 2023: $504 · 2024: $35.38 · 2025: $1,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,340 · Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,339.96 |
| Food and Beverage | $1,008.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,901.35 | 2020-2025 | |
| Stryker Corporation | $1,749.34 | 2021-2025 | Axsos, T2, Variax |
| Medical Device Business Services, INC. | $729.01 | 2021-2025 | Actis |
| Ethicon US, LLC | $101.26 | 2019-2022 | |
| Arthrex, INC. | $85.58 | 2025 | |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Alaska Medical Technologies, LLC | $53.96 | 2025 | |
| Acumed LLC | $42.96 | 2023 | Acumed |
| Smith+Nephew, INC. | $39.28 | 2021-2023 | Renasys Go V2 Home, Pico |
| Ferring Pharmaceuticals INC. | $32.71 | 2019-2021 | |
| Mimedx Group, INC. | $29.91 | 2025 | |
| Bioventus LLC | $17.32 | 2025 | Exogen Ultrasound Bone Healing System |
| Becton, Dickinson and Company | $16.35 | 2021 | |
| Abbott Laboratories | $15.38 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Prevost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.